Voyager Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 37 U.S.-traded ETFs. VYGR has around 2.8M shares in the U.S. ETF market. The largest ETF holder of VYGR is the SPDR S&P Biotech ETF (XBI), with approximately 835.25K shares. Investors may also find of interest that the ETF with the largest allocation to VYGR stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 0.76%. On average, U.S. ETFs allocate 0.10% of VYGR to their portfolios.
Additionally, VYGR is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VYGR as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 48.59%.